COHERUS BIOSCIENCES I
0.8200
07-November-24 14:59:58
15 minutes delayed
Stocks
+0.0962
+13.29%
Today's range
0.7610 - 0.9550
ISIN
N/A
Source
NASDAQ
-
Coherus Prices Public Offering of Common Stock
16 May 2023 05:50:00 By Nasdaq GlobeNewswire
-
Coherus Announces Proposed Public Offering of Common Stock
15 May 2023 15:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
08 May 2023 15:05:02 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in May
04 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
01 May 2023 15:07:00 By Nasdaq GlobeNewswire
-
27 Apr 2023 07:05:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
06 Mar 2023 15:01:00 By Nasdaq GlobeNewswire
-
FDA Approves UDENYCA® Autoinjector
06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in March
01 Mar 2023 07:25:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
28 Feb 2023 07:25:00 By Nasdaq GlobeNewswire
-
13 Feb 2023 07:25:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
03 Feb 2023 16:30:09 By Nasdaq GlobeNewswire
-
09 Jan 2023 07:20:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 06:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
08 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
01 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
12 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United States on October 3, 2022
19 Sep 2022 06:30:00 By Nasdaq GlobeNewswire